These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2582255)

  • 1. An analysis of serum samples positive for HTLV-III antibodies.
    Petricciani JC; Seto B; Wells M; Quinnan G; McDougal JS; Bodner AJ
    N Engl J Med; 1985 Jul; 313(1):47-8. PubMed ID: 2582255
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?
    Osterholm MT; Bowman RJ; Chopek MW; McCullough JJ; Korlath JA; Polesky HF
    N Engl J Med; 1985 May; 312(18):1185-9. PubMed ID: 2984568
    [No Abstract]   [Full Text] [Related]  

  • 3. Consensus development summaries. The impact of routine HTLV-III antibody testing of blood and plasma donors on public health. National Institutes of Health.
    Conn Med; 1986 Nov; 50(11):745-51. PubMed ID: 3466770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 5. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
    Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-HTLV-III antibodies. Methods of detection and biological significance].
    Ercilla MG; Barrera JM
    Med Clin (Barc); 1986 Jan; 86(3):123-5. PubMed ID: 3457227
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors.
    Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C
    N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel agglutination test for the human immunodeficiency virus antibody: a comparative study with enzyme-linked immunosorbent assay and immunofluorescence.
    Yoshida T; Matsui T; Kobayashi S; Harada S; Kurimura T; Hinuma Y; Yamamoto N
    Jpn J Cancer Res; 1986 Dec; 77(12):1211-3. PubMed ID: 3102425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The journal of infection control nursing. AIDS Q&A.
    Nurs Times; 1987 Jun 3-9; 83(22):75. PubMed ID: 3037502
    [No Abstract]   [Full Text] [Related]  

  • 10. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany.
    Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P
    Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HTLV III testing of blood donors and recipients, Hawaii experience.
    Frohlich J
    Hawaii Med J; 1986 Nov; 45(11):391-2. PubMed ID: 3468095
    [No Abstract]   [Full Text] [Related]  

  • 15. Interpretation of tests for the HTLV-III and hepatitis viruses.
    Vellend H
    Trans Assoc Life Insur Med Dir Am; 1987; 70():177-87. PubMed ID: 3474821
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of antibodies to HTLV-III: a comparison of various ELISA methods as screening tests and the Western Blot with immunofluorescence as confirmatory procedures].
    Hengster P; Larcher C; Pöckl E; Schulz T; Wachter H; Dierich MP
    Wien Klin Wochenschr; 1987 Feb; 99(4):112-4. PubMed ID: 3554776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-III infection in Canada in 1985.
    Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
    CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between enzyme-linked immunosorbent and I.F. assays in the serological diagnosis of HIV infections.
    Borghi V; De Palma M; Vecchi M; Pellegrino F; Mongiardo N; Cocchi I; De Rienzo B; Squadrini F
    Microbiologica; 1988 Jan; 11(1):81-4. PubMed ID: 3280951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
    Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
    N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
    Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
    AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.